Zeitschriftenartikel zum Thema „Minimal pharmacophores“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Minimal pharmacophores" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Mortier, Jérémie, Pratik Dhakal und Andrea Volkamer. „Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces“. Molecules 23, Nr. 8 (06.08.2018): 1959. http://dx.doi.org/10.3390/molecules23081959.
Der volle Inhalt der QuellePetrikaite, Vilma, Eduardas Tarasevišius und Alvydas Pavilonis. „New ethacridine derivatives as the potential antifungal and antibacterial preparations“. Medicina 43, Nr. 8 (11.08.2007): 657. http://dx.doi.org/10.3390/medicina43080084.
Der volle Inhalt der QuelleSpasov, Alexander, Irina Ovchinnikova, Olga Fedorova, Yulia Titova, Denis Babkov, Vadim Kosolapov, Alexander Borisov et al. „Amino Derivatives of Diaryl Pyrimidines and Azolopyrimidines as Protective Agents against LPS-Induced Acute Lung Injury“. Molecules 28, Nr. 2 (11.01.2023): 741. http://dx.doi.org/10.3390/molecules28020741.
Der volle Inhalt der QuelleMishra, Pranjali, Muskan Srivastav, Yashveer Gautam, Monal Singh, Neeraj Verma, Deepak S. Kapkoti, Shailendra P. Singh, Anil K. Singh und Devendra P. Rao. „A REVIEW IN CURCUMINOIDS: CHEMISTRY, ANTICANCER ACTIVITY AND FUTURE PROSPECTS“. INDIAN DRUGS 61, Nr. 05 (28.05.2024): 7–23. http://dx.doi.org/10.53879/id.61.05.14041.
Der volle Inhalt der QuelleMaatuf, Yossi, Matan Geron und Avi Priel. „The Role of Toxins in the Pursuit for Novel Analgesics“. Toxins 11, Nr. 2 (23.02.2019): 131. http://dx.doi.org/10.3390/toxins11020131.
Der volle Inhalt der QuelleWermelinger, Guilherme Freimann, Lucas Rubini, Anna Carolina Carvalho da Fonseca, Gabriel Ouverney, Rafael P. R. F. de Oliveira, Acácio S. de Souza, Luana S. M. Forezi, Gabriel Limaverde-Sousa, Sergio Pinheiro und Bruno Kaufmann Robbs. „A Novel MDM2-Binding Chalcone Induces Apoptosis of Oral Squamous Cell Carcinoma“. Biomedicines 11, Nr. 6 (14.06.2023): 1711. http://dx.doi.org/10.3390/biomedicines11061711.
Der volle Inhalt der QuelleBourne, Yves, Gerlind Sulzenbacher, Laurent Chabaud, Rómulo Aráoz, Zoran Radić, Sandrine Conrod, Palmer Taylor, Catherine Guillou, Jordi Molgó und Pascale Marchot. „The Cyclic Imine Core Common to the Marine Macrocyclic Toxins Is Sufficient to Dictate Nicotinic Acetylcholine Receptor Antagonism“. Marine Drugs 22, Nr. 4 (27.03.2024): 149. http://dx.doi.org/10.3390/md22040149.
Der volle Inhalt der QuelleCaldas Lopes, Eloisi, Shieh Jae-Hung, Srikanth Ambati, Su Tsann-Long, Fabian Correa, Elizabeth Peguero und Malcolm A. S. Moore. „Novel Alkylating Agent, Ureidomustine Exhibit Pre-Clinical Efficacy in B-Cell Lymphoma with Minimal Dose-Limiting Myelotoxicity“. Blood 126, Nr. 23 (03.12.2015): 1556. http://dx.doi.org/10.1182/blood.v126.23.1556.1556.
Der volle Inhalt der QuelleVawhal, Pallavi Kishor, Shailaja B. Jadhav, Sumit Kaushik, Kahnu Charan Panigrahi, Chandan Nayak, Humaira Urmee, Sharuk L. Khan et al. „Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay“. Molecules 28, Nr. 3 (19.01.2023): 1004. http://dx.doi.org/10.3390/molecules28031004.
Der volle Inhalt der QuelleRobertson, Gregory T., Eric J. Bonventre, Timothy B. Doyle, Qun Du, Leonard Duncan, Timothy W. Morris, Eric D. Roche, Dalai Yan und A. Simon Lynch. „In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci“. Antimicrobial Agents and Chemotherapy 52, Nr. 7 (Juli 2008): 2324–34. http://dx.doi.org/10.1128/aac.01651-07.
Der volle Inhalt der QuelleCheng, Jeffrey, Enming Xing, Shabber Mohammed, Emma Montgomery, Lauren Granchie, Christopher Coss und Pui-Kai Li. „Abstract 3106: Design, synthesis, and screening of niclosamide analogs as androgen receptor degraders for hepatocellular carcinoma“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 3106. http://dx.doi.org/10.1158/1538-7445.am2023-3106.
Der volle Inhalt der QuelleAlhadrami, Hani A., Ahmed M. Sayed, Heba Al-Khatabi, Nabil A. Alhakamy und Mostafa E. Rateb. „Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor“. Pharmaceuticals 14, Nr. 6 (05.06.2021): 541. http://dx.doi.org/10.3390/ph14060541.
Der volle Inhalt der QuelleOsborne, Joseph, Naveed Hassan Akhtar, Shankar Vallabhajosula, Anastasia Nikolopoulou, Kevin P. Maresca, Shawn M. Hillier, John L. Joyal et al. „Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC).“ Journal of Clinical Oncology 30, Nr. 5_suppl (10.02.2012): 173. http://dx.doi.org/10.1200/jco.2012.30.5_suppl.173.
Der volle Inhalt der QuelleHall, Ronald G., Jotam Pasipanodya, William C. Putnam, John Griswold, Sharmila Dissanaike, Raja Reddy Kallem, Vindhya Edpuganti und Indhumathy Subramaniyan. „1319. Pharmacokinetics of Ceftolozane/Tazobactam in Patients with Burns“. Open Forum Infectious Diseases 7, Supplement_1 (01.10.2020): S670—S671. http://dx.doi.org/10.1093/ofid/ofaa439.1501.
Der volle Inhalt der QuelleSchlitzer, Martin, Labaniel Rodriguez und Peter F. Kador. „Synthesis of potential aldose reductase inhibitors based on minimal pharmacophore requirements“. Journal of Pharmacy and Pharmacology 53, Nr. 6 (Juni 2001): 831–39. http://dx.doi.org/10.1211/0022357011776180.
Der volle Inhalt der QuellePapke, Roger L., Kinga Chojnacka und Nicole A. Horenstein. „The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor“. Journal of Pharmacology and Experimental Therapeutics 350, Nr. 3 (02.07.2014): 665–80. http://dx.doi.org/10.1124/jpet.114.215236.
Der volle Inhalt der QuelleMagnin, David R., Prakash C. Taunk, James G. Robertson, Aiying Wang, Jovita Marcinkeviciene, Mark S. Kirby und Lawrence G. Hamann. „Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1“. Bioorganic & Medicinal Chemistry Letters 16, Nr. 6 (März 2006): 1731–34. http://dx.doi.org/10.1016/j.bmcl.2005.11.098.
Der volle Inhalt der QuelleJohnston, Alexis, und Adegboyega K. Oyelere. „Abstract 4492: Deferiprone optimization for the treatment of triple-negative breast cancer“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 4492. http://dx.doi.org/10.1158/1538-7445.am2024-4492.
Der volle Inhalt der QuelleCruz, María del Carmen, María Salazar, Yésica Garciafigueroa, Dolores Hernández, Francisco Díaz, Germán Chamorro und Joaquín Tamariz. „Hypolipidemic Activity of New Phenoxyacetic Derivatives Related to α-Asarone with Minimal Pharmacophore Features“. Drug Development Research 60, Nr. 3 (03.10.2003): 186–95. http://dx.doi.org/10.1002/ddr.10281.
Der volle Inhalt der QuelleBjij, Imane, Pritika Ramharack, Shama Khan, Driss Cherqaoui und Mahmoud E. S. Soliman. „Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling“. Molecules 24, Nr. 17 (28.08.2019): 3125. http://dx.doi.org/10.3390/molecules24173125.
Der volle Inhalt der QuelleWood, Daniel J., J. Daniel Lopez-Fernandez, Leanne E. Knight, Islam Al-Khawaldeh, Conghao Gai, Shengying Lin, Mathew P. Martin et al. „FragLites—Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation“. Journal of Medicinal Chemistry 62, Nr. 7 (12.03.2019): 3741–52. http://dx.doi.org/10.1021/acs.jmedchem.9b00304.
Der volle Inhalt der QuelleOstash, Bohdan, Emma Doud und Victor Fedorenko. „The molecular biology of moenomycins: towards novel antibiotics based on inhibition of bacterial peptidoglycan glycosyltransferases“. Biological Chemistry 391, Nr. 5 (01.05.2010): 499–504. http://dx.doi.org/10.1515/bc.2010.053.
Der volle Inhalt der QuelleGozalbes, Rafael, Silvia Mosulén, Rodrigo J. Carbajo und Antonio Pineda-Lucena. „Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors“. Journal of Computer-Aided Molecular Design 23, Nr. 8 (07.05.2009): 555–69. http://dx.doi.org/10.1007/s10822-009-9269-0.
Der volle Inhalt der QuelleLadouceur, Gaétan, Dale E. Mais, Joseph A. Jakubowski, Barbara G. Utterback und David W. Robertson. „Structural homologies among thromboxane (TXA2) receptor antagonists: Minimal pharmacophoric requirements for high affinity interaction with TXA2 receptors“. Bioorganic & Medicinal Chemistry Letters 1, Nr. 3 (Januar 1991): 173–78. http://dx.doi.org/10.1016/s0960-894x(01)80794-0.
Der volle Inhalt der QuelleMittal, Ravi K., und Priyank Purohit. „Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent“. Anti-Cancer Agents in Medicinal Chemistry 20, Nr. 16 (05.11.2020): 1981–91. http://dx.doi.org/10.2174/1871520620666200619175906.
Der volle Inhalt der QuelleKhomutov, Maxim A., Fabio Giovannercole, Laura Onillon, Marija V. Demiankova, Byazilya F. Vasilieva, Arthur I. Salikhov, Sergey N. Kochetkov, Olga V. Efremenkova, Alex R. Khomutov und Daniela De Biase. „A Desmethylphosphinothricin Dipeptide Derivative Effectively Inhibits Escherichia coli and Bacillus subtilis Growth“. Biomolecules 13, Nr. 10 (26.09.2023): 1451. http://dx.doi.org/10.3390/biom13101451.
Der volle Inhalt der QuelleDemeter, David A., Herschel J. R. Weintraub und James J. Knittel. „The Local Minima Method (LMM) of Pharmacophore Determination: A Protocol for Predicting the Bioactive Conformation of Small, Conformationally Flexible Molecules“. Journal of Chemical Information and Computer Sciences 38, Nr. 6 (November 1998): 1125–36. http://dx.doi.org/10.1021/ci980404z.
Der volle Inhalt der QuelleJi, Haitao, Benjamin Z. Stanton, Jotaro Igarashi, Huiying Li, Pavel Martásek, Linda J. Roman, Thomas L. Poulos und Richard B. Silverman. „Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase Inhibitors“. Journal of the American Chemical Society 130, Nr. 12 (März 2008): 3900–3914. http://dx.doi.org/10.1021/ja0772041.
Der volle Inhalt der QuelleRasaeifar, Bahareh, Patricia Gomez-Gutierrez und Juan J. Perez. „New Insights into the Stereochemical Requirements of the Bombesin BB1 Receptor Antagonists Binding“. Pharmaceuticals 13, Nr. 8 (17.08.2020): 197. http://dx.doi.org/10.3390/ph13080197.
Der volle Inhalt der QuelleMartinenghi, Laura Daniela, Rie Jønsson, Torben Lund und Håvard Jenssen. „Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L.“ Biomolecules 10, Nr. 6 (12.06.2020): 900. http://dx.doi.org/10.3390/biom10060900.
Der volle Inhalt der QuelleEzekiel, Olugbogi A., Arobadade A. Oluwaotbiloba, Balogun A. Samuel, Adelakun G. Oluwatosin, Maduike N. Mary, Fadeju T. Rasheedat, Kayode O. Yetunde et al. „Application of In-silico Methodologies in Exploring the Antagonistic Potential of Trigonella frenum-graecum on Cyclooxygenase-2 (Cox-2) in Cancer Treatment“. IPS Journal of Molecular Docking Simulations 2, Nr. 1 (15.09.2023): 26–36. http://dx.doi.org/10.54117/ijmds.v2i1.20.
Der volle Inhalt der QuelleZapata-Acevedo, César A., und Paul L. A. Popelier. „The IQA Energy Partition in a Drug Design Setting: A Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B) Case Study“. Pharmaceuticals 15, Nr. 10 (08.10.2022): 1237. http://dx.doi.org/10.3390/ph15101237.
Der volle Inhalt der QuelleMa’arif, Burhan, Faisal Akhmal Muslikh, Luqman Alfani Najib, Ria Ramadhani Dwi Atmaja und Meilina Ratna Dianti. „In Silico Antiosteoporosis Activity of 96% Ethanol Extract of Chrysophyllum cainito L. Leaves“. Proceedings of International Pharmacy Ulul Albab Conference and Seminar (PLANAR) 1 (05.12.2021): 61. http://dx.doi.org/10.18860/planar.v1i0.1460.
Der volle Inhalt der QuelleMotsilanyane, Andrew Rabontsi, Zimbili Mkhize und Sphelele Sosibo. „Computational Studies for Selected Medicinal Plants against Dolutegravir using Ligand Based Pharmacophore, Molecular Docking, ADMET Predictionsand Molecular Dynamics Simulation“. Pakistan Journal of Medical and Health Sciences 16, Nr. 1 (30.01.2022): 927–36. http://dx.doi.org/10.53350/pjmhs22161927.
Der volle Inhalt der QuelleFrancesconi, Valeria, Elena Cichero, Evgeny V. Kanov, Erik Laurini, Sabrina Pricl, Raul R. Gainetdinov und Michele Tonelli. „Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies“. Pharmaceuticals 13, Nr. 11 (14.11.2020): 391. http://dx.doi.org/10.3390/ph13110391.
Der volle Inhalt der QuelleMcBride, Molly J., Sarah R. Pope, Kai Hu, C. Denise Okafor, Emily P. Balskus, J. Martin Bollinger und Amie K. Boal. „Structure and assembly of the diiron cofactor in the heme-oxygenase–like domain of the N-nitrosourea–producing enzyme SznF“. Proceedings of the National Academy of Sciences 118, Nr. 4 (19.01.2021): e2015931118. http://dx.doi.org/10.1073/pnas.2015931118.
Der volle Inhalt der QuelleZhou, Heyang, Niao Yang, Wei Li, Xuemi Peng, Jiaxiao Dong, Yuanying Jiang, Lan Yan, Dazhi Zhang und Yongsheng Jin. „Exploration of Baicalein-Core Derivatives as Potent Antifungal Agents: SAR and Mechanism Insights“. Molecules 28, Nr. 17 (30.08.2023): 6340. http://dx.doi.org/10.3390/molecules28176340.
Der volle Inhalt der QuelleHasan, Md Rifat, Ahad Amer Alsaiari, Burhan Zain Fakhurji, Mohammad Habibur Rahman Molla, Amer H. Asseri, Md Afsar Ahmed Sumon, Moon Nyeo Park, Foysal Ahammad und Bonglee Kim. „Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process“. Molecules 27, Nr. 13 (29.06.2022): 4169. http://dx.doi.org/10.3390/molecules27134169.
Der volle Inhalt der QuelleRaghuvanshi, Rinky, und Sandip B. Bharate. „Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review“. Current Topics in Medicinal Chemistry 20, Nr. 12 (01.06.2020): 1124–35. http://dx.doi.org/10.2174/1568026620666200325110444.
Der volle Inhalt der QuelleHao, Wenhui, Shiying Che, Jinsheng Li, Jingyi Luo, Wanqiu Zhang, Yang Chen, Zijian Zhao, Hao Wei und Weidong Xie. „Synthesis of Berberine and Canagliflozin Chimera and Investigation into New Antibacterial Activity and Mechanisms“. Molecules 27, Nr. 9 (05.05.2022): 2948. http://dx.doi.org/10.3390/molecules27092948.
Der volle Inhalt der QuelleTing, Jasmine U., Maria Carmen S. Tan, Vincent Antonio S. Ng, Stephani Joy Y. Macalino, Virgilio C. Linis und Glenn G. Oyong. „Molecular Simulations of Unexplored Philippine Plant Constituents on the Inhibition of the Proinflammatory Marker NF-κB p50 Subunit“. Crystals 14, Nr. 5 (04.05.2024): 438. http://dx.doi.org/10.3390/cryst14050438.
Der volle Inhalt der QuelleBranco, Jessica R., Vanessa G. Oliveira, Amanda M. Esteves, Ingrid C. Chipoline, Miriam F. O. Lima, Fernanda C. S. Boechat, Fernando C. da Silva et al. „A Novel Naphthotriazolyl-4-oxoquinoline Derivative that Selectively Controls Breast Cancer Cells Survival Through the Induction of Apoptosis“. Current Topics in Medicinal Chemistry 18, Nr. 17 (26.11.2018): 1465–74. http://dx.doi.org/10.2174/1568026618666180821142458.
Der volle Inhalt der QuelleLomovskaya, Olga, Kirk J. Nelson und Debora Rubio-Aparicio. „727. Potency of the β-Lactamase Inhibitor QPX7728 Is Minimally Affected by KPC Mutations that Reduce Potency of Ceftazidime–Avibactam“. Open Forum Infectious Diseases 6, Supplement_2 (Oktober 2019): S326. http://dx.doi.org/10.1093/ofid/ofz360.795.
Der volle Inhalt der QuelleSokolova, K. V., V. V. Stavytskyi, S. О. Konovalova, O. A. Podpletnya, S. I. Kovalenko und A. P. Avdeenko. „Design and search for prospective diuretics (CA II Inhibitors) among aroylhydrazones of esters quinone oxime using in silico and in vivo methodology“. Medicni perspektivi 27, Nr. 4 (29.12.2022): 27–37. http://dx.doi.org/10.26641/2307-0404.2022.4.271120.
Der volle Inhalt der QuelleSacco, Antonio, Cinzia Federico, Arianna Giacomini, Cinzia Caprio, Federica Maccarinelli, Katia Todoerti, Vanessa Favasuli et al. „FGF/FGFR Axis-Blockade Leads to Anti-Tumor Activity in Waldenstrom's Macroglobulinemia By Silencing MYD88“. Blood 136, Supplement 1 (05.11.2020): 43–44. http://dx.doi.org/10.1182/blood-2020-136523.
Der volle Inhalt der QuelleLuthra, Pratibha Mehta, und Nitin Kumar. „Progress and development of C-3, C-6, and N-9 position substituted carbazole integrated molecular hybrid molecules as potential anticancer agents“. Mini-Reviews in Medicinal Chemistry 21 (21.05.2021). http://dx.doi.org/10.2174/1389557521666210521221808.
Der volle Inhalt der QuelleWhitehouse, Rebecca L., Wesam S. Alwan, Olga V. Ilyichova, Ashley J. Taylor, Indu R. Chandrashekaran, Biswaranjan Mohanty, Bradley C. Doak und Martin J. Scanlon. „Fragment screening libraries for the identification of protein hot spots and their minimal binding pharmacophores“. RSC Medicinal Chemistry, 2022. http://dx.doi.org/10.1039/d2md00253a.
Der volle Inhalt der QuelleSingh, Shailja, und Shrawan Kumar Mangawa. „Ferrocene Derivatives as New Generation of Antimalarial Agents: Opportunity or Illusion?“ Current Topics in Medicinal Chemistry 23 (28.02.2023). http://dx.doi.org/10.2174/1568026623666230228153114.
Der volle Inhalt der QuelleKayastha, Forum, Noah B. Herrington, Bandish Kapadia, Anirban Roychowdhury, Nahid Nanaji, Glen E. Kellogg und Ronald B. Gartenhaus. „Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma“. Molecular Medicine 28, Nr. 1 (04.09.2022). http://dx.doi.org/10.1186/s10020-022-00534-0.
Der volle Inhalt der QuelleRath, Santosh Kumar, Sudip Kumar Mandal, Agnidipta Das, Anindya Bose, Vagish Dwibedi, Paramita Ganguly, Sipra Sarkar, Ranjana Prakash, Biplab Kumar Dey und Sanjeet Mandal. „Hetero Cyclic Compounds in the Treatment of Triple-Negative Breast Cancer“. Current Cancer Therapy Reviews 19 (30.12.2022). http://dx.doi.org/10.2174/1573394719666221230111838.
Der volle Inhalt der Quelle